Semler Scientific Inc 's ROA from the third quarter of 2025 to the third quarter of 2024 and 5 Year Period

Return on Assets, Quarterly Results, Trends, Rankings, Statistics

What is Semler Scientific Inc 's ROA in the third quarter of 2025?
Semler Scientific inc achieved a return on average assets (ROA) of 11.76 % in its third quarter of 2025, this is above SMLR's average return on assets of -1.81%.
Semler Scientific Inc assets over the 12 months ending in its third quarter of 2025 are valued at $411 million

ROA decreased relative to the period ending Jun 30 2025, due to the decline in net income.

However, within the Healthcare sector 80 other companies had a higher return on assets. While return on assets, the total ranking has deteriorated compared to the second quarter of 2025 from 436 to 515.

What is ROA?

Select the Comparisons :

None ▼

Select the Ratio:

Return on Assets ROA▼

None ▼

Return on Assets ROA▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

Return On Assets	(Sep 30 2025) III. Quarter	(Jun 30 2025) II. Quarter	(Mar 31 2025) I. Quarter	(Dec 31 2024) IV. Quarter	(Sep 30 2024) III. Quarter
Y / Y Total Assets Change	562.2 %	534.55 %	274.22 %	85.07 %	22.96 %
Y / Y Net Income Change	201.34 %	608381.82 %	-	591.92 %	1.72 %
Net Income (TTM) in million	48	37	-30	41	16
Return On Assets (TTM)	11.76 %	13.02 %	-17.11 %	33.47 %	16.82 %
SMLR's Total Ranking	# 515	# 436	# 3548	# 137	# 259
Total Assets (TTM) in million	596	522	286	240	90
Seq. Total Assets Change	14.27 %	82.4 %	19.05 %	166.87 %	9.49 %
Seq. Net Income Change	-74.75 %	-	-	420.7 %	50890.91 %

SMLR's 5 Years Annual ROA >> Back to SMLR Management Effectiveness >> Compare SMLR ROA to its Competitors

Return On Assets Company Ranking
Within:	No.
Industry	# 20
Sector	# 81
Overall	# 509

Return On Assets Statistics
High	Average	Low
120.02 %	-1.81 %	-237.22 %
(Sep 30 2019)		(Jun 30 2016)

Financial Statements
Semler Scientific Inc 's Assets	$ 596 million	SMLR's Balance sheet
Semler Scientific Inc 's Income	$ 17 million	Quarterly SMLR's Income Statement
SMLR's Income by Division		See SMLR's Income by Division

Annual Return On Assets	(Dec 31 2024) FY 2024	(Dec 31 2023) FY 2023	(Dec 31 2022) FY 2022	(Dec 31 2021) FY 2021	(Dec 31 2020) FY 2020
Y / Y Total Assets Change	231.51 %	25.51 %	14.64 %	45.65 %	89.07 %
Total Assets in million	240	72	58	50	35
Y / Y Net Income Change	98.7 %	43.69 %	-16.82 %	22.95 %	-7.14 %
Net Income in million	41	21	14	17	14
Annual Return On Assets	17.03 %	28.41 %	24.81 %	34.2 %	40.51 %

SMLR's 5 Years Annual ROA >> Back to SMLR Management Effectiveness >> Compare SMLR ROA to its Competitors

Comment on SMLR's ROA in the fiscal year ending 2024

In the fiscal year 2024 ROA deteriorated to 17.03 %, despite annual net income growth of 98.7 % to $40.90 million, from $20.58 million a year ago, as SMLR's assets increase to $240.20 million, by 98.7 %.

More Return On Assets Ratios
SMLR's' Return on Assets at Yahoo Finance
Medical Equipment & Supplies Industry Return On Assets Trends and Statistics
Healthcare Sector Roa Statistics
Roa Trends for overall market
SMLR's Roa Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and overall Market
Highest Ranking Return On Assets
Lowest Ranking Return On Assets
Subscribers only: Roa for SMLR's Competitors
Subscribers only: Roa for Semler Scientific Inc 's Suppliers
Subscribers only: Return On Assets for SMLR's Customers

You may also want to know
SMLR's Roi	SMLR's Inventory Turnover Ratio	SMLR's Growth Rates	SMLR's Dividend Comparisons
	SMLR's Profitability Ratios	SMLR's Asset Turnover Ratio	SMLR's Dividend Growth
SMLR's Roe	SMLR's Valuation Ratios	SMLR's Financial Strength Ratios	SMLR's Dividend Payout Ratio

Companies with similar Return On Assets at Sep 30 2025, within Healthcare Sector	ROA
Ptc Therapeutics inc	31.20 %
Siga Technologies Inc	31.08 %
Idexx Laboratories Inc	31.08 %
Halozyme Therapeutics Inc	27.91 %
Sbc Medical Group Holdings Incorporated	27.36 %
Oramed Pharmaceuticals Inc	25.61 %
Novavax inc	25.46 %
Sab Biotherapeutics Inc	25.33 %
Mettler toledo International Inc	24.95 %
Rafael Holdings Inc	24.26 %
Medpace Holdings Inc	23.65 %
Catalyst Pharmaceuticals Inc	23.00 %
Acadia Pharmaceuticals Inc	21.42 %
Longduoduo Co Ltd	21.36 %
Synlogic Inc	21.18 %
Incyte Corporation	20.37 %
Cytomx Therapeutics Inc	20.29 %
Iradimed Corporation	20.12 %
Eli Lilly And Company	19.18 %
Resmed Inc	18.60 %
Pro dex Inc	18.48 %
Puma Biotechnology Inc	18.32 %
Zoetis Inc	18.15 %
Krystal Biotech Inc	17.65 %
Harmony Biosciences Holdings inc	16.99 %
Abbott Laboratories	16.89 %
United Therapeutics Corporation	16.75 %
Chemed Corporation	16.55 %
Zevra Therapeutics Inc	16.11 %
Merck and Co Inc	15.89 %

Date modified: 2026-09-08T22:21:14+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.